Stockscreener 앱 받기
208.95
2.31%
4.71
시간 외 거래:
208.95
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
Ligand Pharmaceuticals (LGND) Is Up 8.1% After Swinging to Profit and Filing New Equity ShelfWhat's Changed - simplywall.st
[144] LIGAND PHARMACEUTICALS INC SEC Filing - Stock Titan
Ligand plans three March investor appearances in Miami, Dana Point, NYC - Stock Titan
Ligand Pharma (LGND) Earnings Call Transcript - AOL.com
Ligand Pharmaceuticals (LGND): Investor Outlook With 20.74% Potential Upside - DirectorsTalk Interviews
LGND: 2025 Results & Focus on Qtorin - Yahoo Finance
Ligand Pharmaceuticals (LGND) Is Up 7.8% After Swing to Profit and New ATM Offering Filed – Has The Bull Case Changed? - Yahoo Finance
Expert Outlook: Ligand Pharmaceuticals Through The Eyes Of 5 Analysts - Sahm
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com
LGND Should I Buy - Intellectia AI
Decoding Ligand Pharmaceuticals Inc (LGND): A Strategic SWOT Ins - GuruFocus
Ligand Pharmaceuticals Files For Mixed Shelf Offering - TradingView
Ligand Pharmaceuticals (NASDAQ: LGND) files S-3 for $100M ATM offering with Leerink - Stock Titan
LIGAND PHARMACEUTICALS INC SEC 10-K Report - TradingView
Oppenheimer Raises Price Target for LGND, Maintains Outperform R - GuruFocus
Oppenheimer Adjusts Price Target on Ligand Pharmaceuticals to $277 From $275, Maintains Outperform Rating - marketscreener.com
Vanguard Group Inc. Has $367.79 Million Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Oppenheimer raises Ligand Pharma stock price target on royalty outlook By Investing.com - Investing.com Canada
Ligand Pharmaceuticals (NASDAQ:LGND) Announces Quarterly Earnings Results, Beats Expectations By $0.56 EPS - MarketBeat
Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Ligand Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Ligand Pharmaceuticals Inc (LGND) Q4 2025 Earnings Call Highligh - GuruFocus
Ligand Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ligand Pharmaceuticals Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Operating cash flow per share of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ - TradingView
Ligand Pharmaceuticals Incorporated Reiterates Earnings Guidance for the Year 2026 - marketscreener.com
Ligand Pharmaceuticals Q4 Adjusted Net Income, Revenue Rise; Reaffirms 2026 Guidance - marketscreener.com
Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2026 Earnings Guidance - MarketBeat
Ligand (LGND) Surpasses Q4 Revenue Expectations with Robust Perf - GuruFocus
(LGND) Ligand Pharmaceuticals Expects 2026 Total Revenue Range $245M-$285M, vs. FactSet Est of $265.7M - marketscreener.com
(LGND) Ligand Pharmaceuticals Expects 2026 Adjusted EPS Range $8.00-$9.00, vs. FactSet Est of $8.42 - marketscreener.com
Ligand: Q4 Financial Results Overview - Bitget
Earnings Flash (LGND) Ligand Pharmaceuticals Incorporated Reports Q4 Revenue $59.7M, vs. FactSet Est of $55.6M - marketscreener.com
Earnings Flash (LGND) Ligand Pharmaceuticals Incorporated Posts Q4 Adjusted EPS $2.02 per Share, vs. FactSet Est of $1.50 - marketscreener.com
Ligand Pharmaceuticals Reports Strong Q4 and Full Year 2025 Financial Results - TradingView
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
BRIEF-Ligand Pharmaceuticals Q4 EPS USD 2.12 - TradingView
Pharma group Ligand swings from loss to $124M profit as royalties jump - Stock Titan
Total debt per share of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ - TradingView
H.C. Wainwright Maintained Buy on Ligand (LGND) Feb 24, 2026 - Meyka
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $239.00 at HC Wainwright - Defense World
Net current asset value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Operating cash flow per share of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Free cash flow per share of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Total debt per share of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $239.00 - MarketBeat
LGND Analyst Rating Update: HC Wainwright & Co. Raises Price Tar - GuruFocus
Ligand Pharmaceuticals IncorporatedEquity Right (LGNXZ) Price Target Increased by 68.71% to 0.00 - Nasdaq
State of New Jersey Common Pension Fund D Takes $2.40 Million Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated $LGND Shares Bought by Envestnet Asset Management Inc. - Defense World
Volatility Watch: Is Ligand Pharmaceuticals Incorporated being accumulated by smart moneyPortfolio Gains Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Isthmus Partners LLC Sells 7,775 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Will Ligand Pharmaceuticals Incorporated stock deliver consistent dividendsBuy Signal & Intraday High Probability Setup Alerts - mfd.ru
Why Ligand Pharmaceuticals Incorporated stock is a must watch in 20252025 Top Decliners & Fast Moving Trade Plans - mfd.ru
Ligand Pharmaceuticals (LGND) to Release Quarterly Earnings on Thursday - MarketBeat
MSN Money - MSN
Ligand (NASDAQ: LGND) CFO reports PSU and RSU vesting with tax-withheld shares - Stock Titan
Quarterly Earnings: Is Ligand Pharmaceuticals Incorporated in a bullish channel2025 Earnings Surprises & Free Reliable Trade Execution Plans - baoquankhu1.vn
This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge - The Motley Fool
Ligand Pharmaceuticals (NASDAQ:LGND) Stock Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Public Sector Pension Investment Board Grows Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Assessing Ligand Pharmaceuticals (LGND) Valuation After Recent Mixed Share Price Performance - Yahoo Finance
What is Ligand Pharmaceuticals Incorporated’s market position2025 Macro Impact & AI Forecast Swing Trade Picks - mfd.ru
Cibc World Market Inc. Increases Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a long term uptrend2025 Major Catalysts & Capital Efficiency Focused Ideas - mfd.ru
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2025 Financial Results Call Scheduled for February 26, 2026 - Quiver Quantitative
Biopharma company Ligand to reveal 2025 results Feb. 26 - Stock Titan
Is Ligand Pharmaceuticals Incorporated subject to activist investor interest2025 Big Picture & Reliable Entry Point Trade Alerts - mfd.ru
0.11%
6.00%
자본화:
|
볼륨(24시간):